You are here

Article Text

Article menu
Download PDFPDF
Quality improvement
The implementation of a cystic fibrosis annual review process in a tertiary paediatric hospital
  1. Raffaela Armiento,
  2. Sarath C Ranganathan,
  3. Joanne Harrison
  1. Respiratory Medicine, Royal Children’s Hospital, Melbourne, Victoria, Australia
  1. Correspondence to Dr Raffaela Armiento, Respiratory Medicine, Royal Children’s Hospital Melbourne, Parkville, VIC 3052, Australia; raff.armiento{at}gmail.com

Abstract

We evaluated the implementation of a cystic fibrosis annual review process in a tertiary paediatric hospital. After implementation, there was demonstrated improvement in an important outcome measure—the use of inhaled mucolytic agents.

  • cystic fibrosis
  • annual review
  • mucolytic agents
  • quality improvement

https://doi.org/10.1136/archdischild-2017-313455

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Footnotes

    • Competing interests None declared.

    • Provenance and peer review Not commissioned; externally peer reviewed.